(Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 296.93%7.89M | 61.30%-2.92M | -131.43%-1.27M | 169.45%1.11M | 125.66%3.17M | 19.45%1.99M | -392.32%-7.54M | 104.66%4.04M | -733.93%-1.6M | 142.50%1.4M |
Net income from continuing operations | -2,651.67%-1.53M | 38.56%-231K | -1,420.54%-1.7M | -5,009.22%-1.93M | 41.42%544.64K | 107.91%60K | -225.65%-376K | -107.48%-112K | -105.86%-37.81K | 384.96%385.11K |
Operating gains losses | --0 | --21K | ---- | ---- | --843 | ---- | ---- | 372.80%32K | --21.63K | --0 |
Depreciation and amortization | 77.10%2M | 26.01%1.31M | 30.01%4.45M | 1.57%1.08M | 48.83%1.19M | 30.11%1.13M | 52.14%1.04M | 38.93%3.42M | 71.67%1.07M | 6.69%801.7K |
Asset impairment expenditure | --0 | --0 | --1.86M | --1.61M | --0 | --0 | --250K | --0 | --0 | --0 |
Unrealized gains and losses of investment securities | --79K | --80K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Remuneration paid in stock | --132K | --134K | -43.57%281K | 114.95%185K | -62.32%96K | --0 | --0 | 47.76%498K | 8.68%86.07K | 225.27%254.79K |
Deferred tax | 66.13%-147K | -10.95%-233K | -39.83%-839K | 2.53%-178.58K | 89.39%-16.43K | -242.81%-434K | -55.18%-210K | -31.11%-600K | 59.97%-183.21K | ---154.87K |
Other non cashItems | 130.56%332K | 7.46%-211K | 24.88%256K | 94.60%179K | 321.75%161K | 161.01%144K | -274.78%-228K | 417.90%205K | 459.73%91.98K | -723.70%-72.61K |
Change In working capital | 552.32%7.02M | 52.72%-3.79M | -1,035.57%-5.58M | 106.67%176.59K | 527.72%1.19M | -31.54%1.08M | -639.99%-8.02M | 131.49%596K | -307.03%-2.65M | 157.26%189.16K |
-Change in receivables | 754.06%8.83M | 61.32%-1.74M | -31.19%-3.73M | -84.79%-2.4M | 172.50%2.13M | 10.93%1.03M | -1,074.22%-4.5M | -1.50%-2.84M | -107.86%-1.3M | -189.53%-2.94M |
-Change in prepaid assets | -255.72%-715K | 178.70%170K | -595.52%-332K | 2.75%58.45K | -81.63%26.55K | -163.18%-201K | -271.96%-216K | 151.94%67K | -53.27%56.89K | 88.43%144.56K |
-Change in payables and accrued expense | -551.44%-1.1M | 32.74%-2.22M | -144.86%-1.51M | 164.78%2.51M | -117.25%-971.56K | -63.08%243K | -442.01%-3.3M | 224.82%3.37M | -4,457.84%-3.88M | 933.02%5.63M |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.65M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 296.93%7.89M | 61.30%-2.92M | -131.43%-1.27M | 169.45%1.11M | 125.66%3.17M | 19.45%1.99M | -392.32%-7.54M | 104.66%4.04M | -733.93%-1.6M | 142.50%1.4M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 18.41%-811K | -6,766.57%-23.21M | 73.70%-3.33M | 36.69%-1.43M | 93.92%-570.14K | -324.62%-994K | 57.77%-338K | 21.24%-12.67M | -110.53%-2.26M | -1,197.91%-9.37M |
Net PPE purchase and sale | 78.88%-68K | 68.87%-33K | -50.31%-487K | -106.62%-12.45K | 74.60%-46.55K | -144.44%-322K | 46.24%-106K | 82.61%-324K | 119.60%188.16K | 69.58%-183.26K |
Net intangibles purchas and sale | -132.61%-749K | -175.86%-640K | -3,113.33%-1.45M | -73,876.91%-368.41K | ---523.6K | -1,762.46%-322K | -752.53%-232K | 39.04%-45K | 97.37%-498 | --0 |
Net business purchase and sale | --0 | ---22.61M | 89.12%-1.33M | 60.31%-981K | --0 | ---350K | --0 | 12.29%-12.24M | ---2.47M | ---- |
Net other investing changes | --6K | --71K | -11.67%-67K | ---- | ---- | ---- | ---- | 68.87%-60K | 129.42%27.32K | 674.06%573.74K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 18.41%-811K | -6,766.57%-23.21M | 73.70%-3.33M | 36.69%-1.43M | 93.92%-570.14K | -324.62%-994K | 57.77%-338K | 21.24%-12.67M | -110.53%-2.26M | -1,197.91%-9.37M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -491.81%-6.21M | 780.15%25.76M | -94.35%625K | 973.39%939.38K | -120.46%-2.19M | -324.77%-1.05M | 48,241.45%2.93M | -28.86%11.07M | 94.68%-107.56K | 1,031.20%10.71M |
Net issuance payments of debt | -475.97%-6.23M | 710.38%25.76M | -86.85%1.35M | 1,342.74%1.34M | -119.57%-2.08M | -670.21%-1.08M | 3,186.95%3.18M | 21.05%10.3M | 94.91%-107.9K | 977.73%10.65M |
Net common stock issuance | --0 | --0 | ---515K | ---1.47K | ---107.53K | ---135K | ---271K | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | -89.22%18K | --0 | -75.75%186K | -99.71%1 | -100.00%-1 | -72.52%167K | -80.39%19K | 101.23%767K | -99.65%340 | -1.36%62.14K |
Net other financing activities | ---- | ---- | ---400K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -491.81%-6.21M | 780.15%25.76M | -94.35%625K | 973.39%939.38K | -120.46%-2.19M | -324.77%-1.05M | 48,241.45%2.93M | -28.86%11.07M | 94.68%-107.56K | 1,031.20%10.71M |
Net cash flow | ||||||||||
Beginning cash position | 346.02%785K | -77.58%1.15M | 90.95%5.13M | -94.24%523.9K | -98.13%119K | -96.05%176K | 90.98%5.13M | 117.46%2.68M | 64.62%9.09M | -6.83%6.35M |
Current changes in cash | 1,612.28%862K | 92.64%-364K | -262.88%-3.98M | 115.75%624.91K | -85.22%405.09K | -103.01%-57K | -379.25%-4.95M | 68.44%2.44M | -39.74%-3.97M | 311.83%2.74M |
End cash Position | 1,284.03%1.65M | 346.02%785K | -77.58%1.15M | -77.58%1.15M | -94.24%523.9K | -98.13%119K | -96.05%176K | 90.98%5.13M | 90.98%5.13M | 64.62%9.09M |
Free cash from | 426.43%7.07M | 54.42%-3.59M | -194.68%-3.2M | 143.23%733.54K | 112.82%2.6M | -10.79%1.34M | -434.54%-7.88M | 13,922.80%3.38M | -133.71%-1.7M | 2,253.09%1.22M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.